You are here

Yondelis

FDA approves J&J's chemotherapy Yondelis

Yahoo/Reuters

Fri, 10/23/15 - 11:11 am

soft tissue sarcomas

Speedy US review for J&J sarcoma drug Yondelis

Pharma Times

Tue, 02/3/15 - 11:31 am

priority review

J&J hopes third time is the charm for antitumor agent Yondelis

Fierce Biotech

Tue, 11/25/14 - 03:53 pm

Zeltia Plans Europe Drug Sales Force in Market-Share Push

Bloomberg

Thu, 04/12/12 - 11:24 am

Zeltia Soars After Agreement With Janssen on Yondelis for U.S.

Bloomberg

Tue, 12/27/11 - 12:31 pm

Janssen Pharmaceuticals

Zeltia Says Yondelis-Related Drug May Suffer Supply Constraints

Bloomberg

Tue, 08/9/11 - 01:48 pm

Zeltia to Miss $10 Million Yondelis Payment After U.S. Setback

Bloomberg

Sun, 05/1/11 - 04:23 pm

EU agency backs Zeltia drug for ovarian cancer

Reuters

Fri, 09/25/09 - 10:32 am

FDA wants more data about Johnson & Johnson's ovarian cancer drug Yondelis

Yahoo/AP

Thu, 09/10/09 - 05:47 pm

Keep Your Chin Up, J&J

Motley Fool

Thu, 07/16/09 - 04:34 pm

FDA Calendar Updates: Johnson & Johnson, Cadence, Watson, Targacept

Seeking Alpha

Thu, 07/16/09 - 09:14 am

Cadence Pharmaceuticals

Watson Pharmaceuticals

FDA panel overwhelmingly says risks of J&J ovarian cancer drug outweigh potential benefits

Yahoo/AP

Thu, 07/16/09 - 08:53 am

FDA questions reliability of data for Johnson & Johnson's ovarian cancer drug Yondelis

Yahoo/AP

Mon, 07/13/09 - 11:26 am